Product Details

Vermid is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Midazolam for use as a short-acting benzodiazepine sedative. As a result, it offers fast-onset sedation, anxiolysis, and amnesia for procedural and peri-operative settings.

The injection contains:

• Midazolam BP – A short-acting benzodiazepine that enhances GABA-A receptor activity in the central nervous system. Consequently, it produces rapid sedation, anxiolysis, muscle relaxation, and anterograde amnesia, along with a comparatively quick recovery profile.

Anaesthetists and physicians use Vermid for procedural sedation, premedication before anaesthesia, and as a component of induction and maintenance of general anaesthesia. In addition, its rapid onset and short duration make it suitable for conscious sedation during diagnostic and minor surgical procedures. Because of this profile, Vermid suits operating theatres, ICUs, and endoscopy or day-care procedural units where controlled, titratable sedation is essential.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the fast-onset, short-acting profile supports precise, titratable sedation
• Furthermore, each vial delivers precise, validated dosage accuracy
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and procedural care units